Logo

Jazz Pharmaceuticals plc

JAZZ

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and… read more

Healthcare

Biotechnology

18 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$227.72

Price

-1.44%

-$3.33

Market Cap

$14.288b

Large

Price/Earnings

2,070.2x

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

+37.0%

EBITDA Margin

+27.4%

Net Profit Margin

+36.4%

Free Cash Flow Margin

+37.0%

EBITDA Margin

+27.4%

Net Profit Margin

+36.4%

Free Cash Flow Margin
Revenue

$4.439b

+4.0%

1y CAGR

+5.0%

3y CAGR

+5.0%

5y CAGR
Earnings

$29.493m

+108.3%

1y CAGR

-6.8%

3y CAGR

+66.2%

5y CAGR
EPS

$0.11

+101.9%

1y CAGR

-7.9%

3y CAGR

+61.6%

5y CAGR
Book Value

$4.532b

$11.860b

Assets

$7.327b

Liabilities

$5.417b

Debt
Debt to Assets

45.7%

13.7x

Debt to EBITDA
Free Cash Flow

$1.246b

-4.0%

1y CAGR

+6.2%

3y CAGR

+14.1%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases